13F Pro

SEC Form 4 reporting owner

Szot Matthew K

Szot Matthew K has filed 4 Form 4 transactions reported between December 3, 2025 and June 15, 2026, as Director of SenesTech, Inc., Chief Financial Officer of Cadrenal Therapeutics, Inc. and Director of INVO Fertility, Inc..

Name as filed: Szot Matthew K

Open-market buys, 24 mo
None
reported
Open-market sales, 24 mo
$69K
1 lines
Companies
3
with Form 4 filings
Latest transaction
Jun 15, 2026
transaction date

Roles and reported holdings

  • SNESSenesTech, Inc.
    Jun 15, 2026

    Director

    No common-stock holding reported on a purchase, sale, gift or withholding line.

  • CVKDCadrenal Therapeutics, Inc.
    Dec 29, 2025

    Chief Financial Officer

    Held directly0 sh as of Dec 29, 2025 · Form 4

    24 months: $69K sold

  • IVFINVO Fertility, Inc.
    Dec 3, 2025 – Dec 4, 2025

    Director

    No common-stock holding reported on a purchase, sale, gift or withholding line.

    1 line is priced far from IVF’s market price that day, so the filing may concern a different security. Left out of totals and holdings; see the filings.

Transaction history

All 4 reported transactions, newest first. Every row links to the Form 4 on SEC EDGAR.

DateCompanyTypeSharesValueFiling
Jun 15, 2026SNESDirectorGrant or awardCode A · direct100,000—Form 4
Dec 29, 2025CVKDChief Financial OfficerOpen-market saleCode S · direct9,933$69K@ $6.97Form 4
Dec 4, 2025IVFDirectorOther acquisition or dispositionCode J · direct3—Form 4
Dec 3, 2025IVFDirectorOpen-market saleCode S · directPrice far from market; may be another security4$6@ $1.52Form 4

How this page is built

Every row comes from a Form 4 filed with the SEC, which officers, directors and holders of more than 10% of a company’s stock must file within two business days of a trade. Transactions are grouped by the reporting owner’s name as filed (spacing, capitals and punctuation ignored); two different people filing under an identical name would appear together, and one person filing under two spellings appears on two pages.

Open-market totals count code P purchases and code S sales over the last 24 months. The same trade reported on more than one filing is counted once; when another owner (for example a fund and its general partner) reports the identical trade, they are listed beside it. Holdings are the shares owned after the latest purchase, sale, gift or tax-withholding line, shown separately for direct and indirect ownership; an indirect figure is one holding line, not a total across every trust or entity.

1 open-market line is priced outside 0.67×–1.5× of the stock’s closing price that day. A gap that large usually means the filing reports a different security than the company it is filed under, so those lines are shown but left out of totals and holdings.

This page describes what was filed with the SEC; it is not investment advice or a recommendation to buy or sell any security.